radiotherapy by computational methods
|
|
- Samson Fleming
- 8 years ago
- Views:
Transcription
1 Evaluating 99m Tc Auger electrons for targeted tumor radiotherapy by computational methods Adriana Alexandre S. Tavares a) and João Manuel R. S. Tavares b) Faculdade de Engenharia da Universidade do Porto (FEUP) Rua Dr. Roberto Frias, S/N, , Porto, Portugal Abstract: Purpose: Technetium-99m ( 99m Tc) has been widely used as an imaging agent but only recently has been considered for therapeutic applications. This study aims to analyze the potential use of 99m Tc Auger electrons for targeted tumor radiotherapy, by evaluating the DNA damage and its probability of correct repair and by studying the cellular kinetics, following 99m Tc Auger electrons irradiation in comparison to Iodine-131 ( 131 I) beta minus particles and Astatine-211 ( 211 At) alpha particle irradiation. Methods: Computational models were used to estimate the yield of DNA damage (fast Monte Carlo damage algorithm), the probability of correct repair (Monte Carlo excision repair algorithm) and cell kinetic effects (virtual cell radiobiology algorithm) after irradiation with the selected particles. Results: The results obtained with the algorithms used suggested that 99m Tc CKMMX (all M-shell Coster-Kroning CK and super CK transitions) electrons and Auger MXY (all M-shell Auger transitions) have a therapeutic potential comparable to high linear energy transfer (LET) 211 At alpha particles and higher than 131 I beta minus particles. All the other 99m Tc electrons had a therapeutic potential similar to 131 I beta minus particles. 1
2 Conclusions: 99m Tc CKMMX electrons and Auger MXY presented a higher probability to induce apoptosis than 131 I beta minus particles and a probability similar to 211 At alpha particles. Based on the results here, 99m Tc CKMMX electrons and Auger MXY are useful electrons for targeted tumor radiotherapy. Keywords: targeted tumor radiotherapy; computational methods; I. Introduction The main characteristics of an ideal radionuclide for targeted tumor radiotherapy include 1 : (a) electrons emitted with energies lower than 40 kev; (b) photonic emission/electron emission ratio lower than 2; (c) half-life between 30 minutes and 10 days; (d) stable daughter nuclide or daughter nuclide with a half-life greater than 60 days; (e) amenable to radiolabeling; (f) economical preparation with high specific activity and radiochemical purity; and (g) efficient incorporation into a selective carrier molecule, which should be able to associate with the DNA complex for the time corresponding to the radionuclide half-life. Other requisites for successful targeted tumor radiotherapy have also been highlighted such as: (a) consecutive internal irradiations using Auger electron emitters must be possible; and (b) systemic radiation therapy must target the radiation homogeneously on a large proportion of all live cancerous cells. 2 Auger electrons have been recognized as potentially useful for targeted tumor radiotherapy, especially due to the Auger electron range (which is in the nanometer order), and the high ionization density of these electrons. 2-6 Previous studies also demonstrated that once Auger electron emitters are introduced close to DNA, the survival curves are similar to those obtained with high LET α particles. 5, 7 Despite these advantages, Auger emitters still have limitations including: long tracer retention times in blood flow and low penetration in certain tumor areas, which can lead to non-uniform doses absorbed in tumors. 4 It is well known that 99m Tc emits less than 1% Auger electrons per decay versus 3.7 to 19.9% for Iodine-125 ( 125 I), Iodine-123 ( 123 I) and Thallium-201 ( 201 Tl). Nevertheless, some potential 2
3 advantages have been pointed out, including: a short half-life; a stable daughter nuclide; Auger electron energies between 0.9 and 15.4 kev; and good availability. Also 99m Tc is obtained economically, as it can be eluted and handled easily from a generator with high specific activity. Furthermore, its ideal characteristics for imaging can allow therapy monitoring and follow-up. 1-2, 8-10 These characteristics and the very small number of studies concerning 99m Tc Auger electrons (for a review see 11 ) motivated us to carry out this work to evaluate the usefulness of these specific Auger electrons for targeted tumor radiotherapy. We used cell radiobiology software 12 and two fast Monte Carlo simulators to: Study the radiobiological effects of 99m Tc Auger electrons by comparing these with other particles emitted by radionuclides currently used for systemic radiotherapy, namely, 131 I (beta minus emitter) and 211 At (alpha emitter). Evaluate the radiobiological effects of 99m Tc Auger electrons in comparison with 131 I beta minus and 211 At alpha particles on two different cell types (human fibroblasts and human intestinal crypt cells). II. Methods Three different computational simulators were used to study the therapeutic potential of 99m Tc Auger electrons This section explains the main principles of these simulators and points out the parameters adopted Fast Monte Carlo Damage Formation Simulator The Monte Carlo damage simulation (MCDS) algorithm is used to predict the types of DNA damage and their yield after irradiation. The model generates a random number of damage configurations expected within the DNA of one cell. This algorithm processes information in two main steps: 1) it randomly distributes, in a DNA segment, the expected amount of damage produced in a cell and 2) subdivides the distribution of damage in that section. The number and spatial distribution of damage configurations predicted by the MCDS algorithm are in reasonable agreement with those predicted by track-structure simulations. Furthermore, the MCDS allows the 3
4 collection of data from multiple irradiation scenarios within a few minutes on a common computer. These characteristics make the MCDS simulator useful for comparing 99m Tc electrons with other particles used for radiotherapy. 14 For a detailed description of the MCDS model as well as additional discussions on the validity and limitations of the model, see, for example, The classification scheme used by the MCDS to categorize DNA damage is based on the classification parameters proposed by Nikjoo et al. (1997), and it comprises essentially: (a) no damage; (b) single-strand breaks (SSB); (c) two strand-breaks on the same strand (SSB + ); (d) two or more strand-breaks on opposite strands separated by at least 10 base pairs (2SSB); (e) two strand-breaks on opposite strands with a separation not greater than 10 base pairs (double strand breaks - DSB); (f) DSB accompanied by one (or more) additional strand breaks within a 10-base pair separation (DSB + ); and (g) more than one DSB, whether within the 10-base pair separation or further apart (DSB ++ ). For further details see Fast Monte Carlo Excision Repair Simulator The Monte Carlo excision repair (MCER) algorithm is used to simulate repair outcomes such as correct repair, repair with a mutation and conversion into a DSB. This Monte Carlo simulation also calculates the formation and repair of damage within one cell. 13 The MCER algorithm starts using the MCDS algorithm to generate a random number of damage configurations expected within the DNA of one cell. Thereafter, the MCDS-generated damage configurations are superimposed over an actual nucleotide sequence or a random nucleotide sequence. Finally, the MCER model is used to simulate the repair, misrepair and aborted excision repair of damage within the entire genome or within a specific region of the DNA. The lesions forming a cluster are removed sequentially through repeated rounds of excision repair. Most DNA oxidative damage, including modified apurinic/apyrimidinic (AP) converted to strand breaks, require repair by base excision repair (BER). Two different types of BER processes have been observed in eukaryotic and prokaryotic cells: 1) excision and replacement of a single nucleotide, known as short-patch BER (SP-BER), which occurs in the majority of cases; and 2) replacement of 2 to 13 nucleotides, known as long-patch BER (LP-BER). Another enzymatically 4
5 distinct repair pathway is nucleotide excision repair (NER). This last repair pathway, observed in eukaryotic cells, substitutes oligonucleotide fragments of 24 to 32 nucleotides in length. 13 The simulator results are presented in terms of three simplified repair scenarios due to the current uncertainties associated with the processing of radiation-induced damage by the BER and NER pathways. According to Semenenko et al. (2005), the simulator results correlate well with in vitro results from cell cultures, despite this simplification. 18 A detailed description of the MCER algorithm as well as additional discussions on the validity and limitations of the model can be found in 13, Virtual Cell Radiobiology Simulator Ionizing radiation frequently causes DSB and other DNA damages in less than one millisecond. Radiation induced damage is processed slowly via enzymatic repair and misrepair, which then determines the fate of the irradiated cell. As far as long time scales are concerned, cell cycle kinetics can influence and be influenced by the kinetics of damage processing. 19 DNA damage is a trigger for apoptosis, although cell membrane damage can also induce apoptosis. 15 The dose-response association, damage production and its repair mechanisms have been largely studied using radiobiological models that correlate the dose rate with cell response. Some of the existing models include: 1) the repair-misrepair model (RMR), 2) lethal-potentially lethal model (LPL) and 3) two-lesion kinetics (TLK). 19 The main disadvantage of the LPL model is its limits to correlate the biochemical processes of DSB with cell death. The RMR and linear quadratic models also have the same limitation. In order to overcome this limitation, the TLK model carries out an improved correlation between the biochemical processes of DSB and cell death by subdividing DSB into simple or complex DSBs. This subdivision is important, since simple and complex DSBs have different repair characteristics. 20 Therefore, simulations carried out with the virtual cell radiobiology simulator (VC) were performed using the TLK model Simulated Parameters 5
6 The 99m Tc spectrum of energies, presented in an AAPM (American Association of Physicists in Medicine) report in 1992, includes electron ranges from 2.05 nm to 251 μm and electron energies ranging between kev and 140 kev. 21 In the present study, all 99m Tc electrons were studied with the exception of Auger CK NNX (all N-shell CK and super CK transitions), due to its low energy (33 ev), which is below the lower energetic limit of the simulator (80 ev). In addition, alpha particles from 211 At and beta minus particles from 131 I were also studied. Further input details for the MCDS and MCER simulators can be found in Table I. Once the comparison between the MCDS and MCER results for 99m Tc electrons, 131 I beta particles and 211 At alpha particles was complete, the two best 99m Tc electrons (with the highest ability to induce DNA damage) were then used to study the kinetics of the cell after irradiation in two different cell types: 1) human fibroblasts (Tc the cell cycle time =0.900 hour and Tpot - potential doubling time=0.667 days) and 2) human intestinal crypt cells (Tc=1.000 hour and Tpot=1.625 days) The cell kinetic study (VC simulator) compared the two best 99m Tc electrons with 131 I beta particles and 211 At alpha particles. The number of DSBs and the percentage of complex DSBs were obtained from the MCDS simulator. These results were then applied as input parameters for the TLK model used on the VC simulator. Irradiation periods of 2, 6 and 24 hours (TCUT time allowed for repair after exposure), with total absorbed doses of 1, 1.5 and 2 Gy were studied using the VC simulator. Other parameters used on the VC simulator, specified in the TLK model input file, include: 1) DRM (damage repair model)=tlk; 2) CKM (cell kinetics model)=qeck (quasi-exponential cell kinetics model); 3) DNA (cell DNA content)=5.667d+09 base pair; 4) DSB (endogenous)=4.3349e-03 Gy -1 cell -1 ; 5) RHT (repair half-time)=xxx, XXX=0.25, 9 hours (simple DSBs are repaired faster than complex DSBs); 6) A0 (probability of correct repair)=aaa, AAA=0.95, 0.25 (simple DSBs are repaired more accurately than complex DSBs); 7) ETA (pairwise damage interaction rate)=2.5e-04 h -1 ; 8) PHI (probability of a misrejoined DSB being lethal)=0.005; 9) GAM (fraction of binarymisrepaired damages that are lethal)=0.25; 10) N0 (initial number of cells)=1000; 11) KAP (peak cell density)=1.0d+38 cells per cm 3 ; 12) VOL (tissue volume)=1 cm 3 ; 13) FRDL (fraction of residual that is lethal damage)=0.5; 14) ACUT (absolute residual-damage cutoff)=1.0d-09 expected number 6
7 of DNA damages per cell; 15) BGDR (average background absorbed dose rate on planet Earth)= E-07 Gy/h; 16) DCUT (dose cutoff)=0.01 Gy; 17) STOL (step-size tolerance)=0.01 Gy/h; 18) SAD (scaled absorbed dose)=rx1, RX1=1, 1.5, 2 Gy; 19) GF (growth fraction, if 0 (zero) all cells are quiescent, if 1 (one) all cells are cycling and if 0.5 the cell population is heterogeneous)=0, 0.5, 1. 12, Statistical Analysis The MCDS results are expressed as a percentage of damage. The MCER results are expressed as a probability of repair or number of cell cycles. The VC values are expressed as the number of lethal damages per cell, number of surviving cells, probability per cell and frequency per irradiated cell. The statistical significance was determined using either the Student t-test or ANOVA (p<0.01) for each group of irradiating agents. III. Results MCDS and MCER Results Results obtained by the MCDS simulator allowed an estimate to be made of the amount of DNA damage following irradiation with 99m Tc electrons, 131 I beta minus particles and 211 At alpha particles, as shown in Fig. 1. Results for the probability of correct repair, repair with a mutation and conversion into a DSB are presented in Fig. 2 and the number of repair cycles is presented in Fig. 3 (MCER simulator). Findings from the MCDS and MCER simulators showed that CKMMX electrons and Auger MXY were the best 99m Tc electrons for targeted tumor radiotherapy. Accordingly, these electrons were used for the study of cell kinetics after irradiation with the VC simulator VC Simulator The results of mutagenesis probability and induction of enhanced genetic instability (defined by the algorithm used as PGA PGH NCG=4.250E-06, with: PGA - probability a mutated gene induces genomic instability, PGH - probability that a randomly formed mutation hits a critical 7
8 gene and NCG - total number of target genes that must be damaged to induce genomic instability) after irradiation with different irradiating agents are shown in Fig. 4a. Statistical analysis showed significant differences between 99m Tc Auger MXY and 131 I beta minus particles (p=0.001, t-test) and also between 211 At alpha particles and 131 I beta minus particles (p=0.0006, t-test). The estimated number of lethal damages per cell due to mutations for all the irradiating agents is presented in Fig. 4b. Additionally, statistically significant differences were observed among the different irradiating agents (p<0.0001, ANOVA). Results for the neoplastic transformation (defined by the algorithm used as a function of dose and dose rate at t=42.0 days) per studied cell for different irradiating agents are presented in Fig. 4c. Once again, statistically significant differences were found among each irradiating agent per studied cell type (fibroblasts and intestinal crypt cells), p< (ANOVA). The estimated number of cells that survived irradiation when all cells were quiescent; when the cell population was heterogeneous (with quiescent cells and cells actively dividing/on cycle); and when all cells were actively dividing is presented in Figs. 5a, 5b and 5c, respectively. Statistically significant differences were observed between 131 I beta minus particles and the other types of radiation when all cells were quiescent (p<0.0001, ANOVA). However, no differences were found between 99m Tc Auger electrons and 211 At alpha particles or between fibroblasts and intestinal crypt cells for all the irradiating agents (Fig. 5a). In contrast, heterogeneous populations yielded statistically significant differences between different cell types for the same irradiating agent (p<0.0001, t-test). Differences among distinct types of irradiating agents in intestinal crypt cells (p<0.0001, ANOVA) and fibroblasts (p=0.0031, ANOVA) were also found in heterogeneous populations (Fig. 5b). For populations of cells actively dividing (Fig. 5c), statistically significant differences were found among distinct irradiating agents in intestinal crypt cells (p=0.0002, ANOVA), but no differences were found among distinct irradiating agents in fibroblasts (p=0.3014, ANOVA). A more detailed analysis showed that no differences were observed between both 99m Tc Auger electrons (CKMMX and Auger MXY, p=0.1406, t-test) or among each 99m Tc Auger electron under study and 211 At alpha particles (CKMMX, p= and Auger MXY, p= t-test). Nevertheless, 8
9 statistically significant differences were observed when comparing 131 I beta minus particles with the other particles studied (p<0.0001, t-test). Finally, statistically significant differences were also observed when comparing the same irradiating agent on the two distinct cell types (p<0.0001, t- test). IV. Discussion and Conclusions MCDS results showed that the percentage of simple and double strand breaks after irradiation was always higher for 99m Tc CKMMX electrons and Auger MXY than for 131 I beta minus particles and was similar to 211 At alpha particles. The same trend was observed for the percentage of complex single and double strand breaks. Furthermore, the remaining 99m Tc electrons obtained by internal conversion were less able to induce DNA damage, which correlates with Pomplun et al. (2006). 25 The results obtained with these conversion electrons were similar to 131 I beta minus particles. This may be explained by the higher tissue range of these 99m Tc electrons, whose behavior is similar to beta minus particles (low LET particles). The MCER outcome showed that the increased amount of DNA damage and its complexity hampers successful repair. Moreover, the probability of correct repair of single strand breaks is lower for 99m Tc CKMMX electrons and Auger MXY than for 131 I beta minus particles and is comparable to 211 At alpha particles. The probability of conversion to DSBs is also higher for 99m Tc electrons than for 131 I beta minus particles. These results were observed for all the repair processes studied, regardless of the repair route. In addition, a higher number of repair cell cycles had been correlated with prolonged repair times, which correlates with increased LET particles. Previous studies observed that complex damage repair by excision leads to an increased number of DSBs. 13 Accordingly, it is well known that DNA double strand breaks are frequently associated with apoptosis induction. 15 Therefore, the observed higher number of DNA double strands induced by 99m Tc CKMMX electron and Auger MXY (MCDS simulator) allied to its higher DNA single strand breaks conversion to double strand breaks (MCER simulator), suggest that the probability of apoptosis induction is likely to be higher for those electrons than for 131 I beta minus particles and comparable to 211 At alpha particles. 9
10 The mutagenesis and enhancement of genetic instability study showed that the best 99m Tc Auger electrons ( 99m Tc CKMMX electron and Auger MXY) had a higher probability of inducing mutagenesis and genetic instability than 131 I beta minus. However, 131 I beta minus particles were the most likely of all the irradiating agents studied to induce neoplastic transformation. Furthermore, the selected 99m Tc Auger electrons had a higher ability to induce lethal damage, due to mutations, than the other particles studied. These results suggest that the higher probability of induced mutagenesis and enhancement of genetic instability of the selected Auger electrons will potentially lead to cell death or benign mutations and not to neoplastic transformation. The findings obtained are consistent with in vitro studies conducted by Pedraza-López et al. (2000) and Ilknur et al. (2002) using lymphocytes The results showed that the various irradiating agents were equally effective at killing quiescent human fibroblast and intestinal crypt cells. In contrast significant differences were seen between irradiating agent and cell types when a mixed population of cycling and quiescent cells were irradiated. These observations highlight the influence of cell proliferation on the radiosensitivity of the cells. For heterogeneous populations, crypt cells were more radiosensitive than fibroblasts. Finally, for cell populations where all cells were actively dividing, the results also showed that the number of cells that survive irradiation was significantly lower for intestinal crypt cells when compared to fibroblasts. Nevertheless, no differences were observed among the distinct irradiating agents studied for actively dividing fibroblast populations, which suggests that cell response to irradiation is radiation type independent. This may be explained by the reduced radiosensitivity of this type of cell and its active proliferation state, which may compensate radiation induced damages by fast continuous cell duplication. Furthermore, intestinal crypt cells showed significant differences among all irradiating agents. This may mean that, due to its longer doubling time (39 hours versus 16 hours for fibroblasts), intestinal crypt cells were unable to compensate radiation induced damage by cell duplication. Häfliger and coworker s in vitro studies (2005) showed that 99m Tc induced double-strand breaks in DNA when decaying in its direct vicinity. 21, 28 In their paper, Häfliger and coworkers cited the Ftacnikova and Bohm (2000) study regarding theoretical calculations of energy deposition into 10
11 DNA According to Ftacnikova and Bohm (2000), the electrons with initial energies from 50 ev to 250 ev have the highest theoretical probability of inducing DNA DSB, because these electrons are able to produce clusters of inelastic interactions in a volume with a diameter of a few nm (which is characteristic of Auger emitters). 29 Based on that, Häfliger et al. listed the Auger electrons emitted by 99m Tc that are potentially the most interesting for targeted tumor radiotherapy: CK MMX electron, Auger MXY electron and CK NNX electron. 28 We used different computational methods to evaluate the 99m Tc electrons spectrum by comparing those with other particles used for radiotherapy. This represents a novel and faster method to evaluate and grade 99m Tc electrons for target tumor radiotherapy. All 99m Tc electrons were considered separately (except CK NNX electron due to simulator limitations) and their radiobiological effects evaluated. Our findings, obtained by means of three different computational simulators, provided evidence that 99m Tc CK MMX electron and Auger MXY electron are useful electrons for targeted tumor radiotherapy. 99m Tc Auger MXY and CKMMX electrons yield 1.1 and electrons per decay - the second and third highest yields of all 99m Tc Auger electrons, respectively. The uppermost yielding electrons are CKNNX with 1.98 electrons per decay, which was not evaluated due to previously explained simulator limitations. These yields are lower than those for 125 I, which yields 1.44 and 3.38 electrons per decay for CKMMX electrons and Auger MXY, respectively. 21 Nevertheless, this potential limitation may be overcome or compensated by the 99m Tc shorter half-life, as shown by previous studies. 1, 8, 10 Moreover, the 99m Tc electron irradiation results correlate with previous findings suggesting that the shorter half-life radionuclides reduce the dose fractioning to daughter cells and increase the absorbed doses per unit of time. 1-6 Higher DNA damage yields have been associated with Auger electrons due to their short range and LET quality. The high abundance of 99m Tc photons is an important factor that may influence the possible therapeutic outcome. Although photons emitted present a high tissue range and thus most energy will be deposited outside the target cell, their dosimetric implications may work as a limiting factor for this kind of target tumor radiotherapy. Nonetheless, these photons could facilitate therapy monitoring and the design of more selective and specific carriers. This may be challenging but would allow the delivery of radiation to a specific targeted cell. 11
12 Computational methods allow rapid and easy data collection. Nonetheless, some limitations have been pointed out, including modeling and evaluation based on current knowledge, which works as a mechanistic process. This disadvantage may underestimate or overestimate the results. Although the results obtained showed correlation with previous in vitro and other computational studies, which suggest that the simulators used may be useful for the characterization of different particles for targeted tumor radiotherapy, further comparison of 99m Tc electrons with other Auger and conversion electrons could provide extra information regarding the potential of 99m Tc as a therapeutic radionuclide. In summary, this study aimed to compare different irradiating agents using the same exposure conditions and controllable cell populations to clarify the potential usefulness of 99m Tc electrons for targeted tumor radiotherapy. An analysis of all the data obtained has led us to conclude that 99m Tc CKMMX electron and Auger MXY presents a higher probability to induce apoptosis than 131 I beta minus particles and a similar one to 211 At alpha particles. This characterizes 99m Tc CKMMX electron and Auger MXY as high LET particles and thus useful for targeted tumor radiotherapy. Acknowledgement The authors wish to thank Dr Robert Stewart (School of Health Sciences Purdue University, USA) for providing the simulator software packages used and for his kind technical assistance. References: a) Electronic adriana_tavares@msn.com b) Electronic tavares@fe.up.pt 1. P. Unak, "Targeted Tumor Radiotherapy," Brazilian Archives of Biology and Technology 45, (2002). 2. F. Buchegger, F. Perillo-Adamer, Y. Dupertuis and A. Delaloye, "Auger Radiation Targeted into DNA: A Therapy Perspective," European Journal of Nuclear Medicine and Molecular Imaging 33, (2006). 12
13 3. R. O'Donnell, "Nuclear Localizing Sequences: An Innovative Way to Improve Targeted Radiotherapy," The Journal of Nuclear Medicine 47, (2006). 4. S. Britz-Cunningham and J. Adelstein, "Molecular Targeting with Radionuclides: State of the Science," The Journal of Nuclear Medicine 44, (2003). 5. C. Boswell and M. Brechbiel, "Auger Electrons: Lethal, Low Energy, and Coming Soon to a Tumor Cell Nucleus Near You," The Journal of Nuclear Medicine 46, (2005). 6. G. Mariani, L. Bodel, S. Adelstein and A. Kassis, "Emerging Roles for Radiometabolic Therapy of Tumors Based on Auger Electron Emission," The Journal of Nuclear Medicine 41, (2000). 7. K. Sastry, "Biological Effects of the Auger Emiter Iodine-125: A Review. Report No.1 of AAPM Nuclear Medicine Task Group No.6," Medical Physics 19, (1992). 8. J. Humm and D. Chariton, "A New Calculational Method to Assess the Therapeutic Potential of Auger Electron Emission," International Journal of Radiation Oncology Biology Physics 17, (1989). 9. F. Marques, A. Paulo, M. Campello, S. Lacerda, R. Vitor, L. Gano, R. Delgado and I. Santos, "Radiopharmaceuticals for Targeted Radiotherapy," Radiation Protection Dosimetry 116, (2005). 10. J. O'Donoghue and T. Wheldon, "Targeted radiotherapy using Auger electron emitters," Physics in Medicine and Biology 41, (1996). 11. A. Tavares and J. Tavares, " 99m Tc Auger Electrons for Targeted Tumour Therapy: A Review," International Journal of Radiation Biology 86, (2010). 12. R. Stewart, "Computational Radiation Biology," (Purdue University, School of Health Sciences, 2004). 13. V. Semenenko, R. Stewart and E. Ackerman, "Monte Carlo Simulation of Base and Nucleotide Excision Repair of Clustered DNA Damage Sites. I. Model Properties and Predicted Trends," Radiation Research 164, (2005). 13
14 14. V. Semenenko and R. Stewart, "A Fast Monte Carlo Algorithm to Simulate the Spectrum of DNA Damages Formed by Ionizing Radiation," Radiation Research 161, (2004). 15. D. Carlson, R. Stewart, V. Semenenko and A. Sandison, "Combined Use of Monte Carlo DNA Damage Simulations and Deterministic Repair Models to Examine Putative Mechanisms of Cell Killing," Radiation Research 169, (2008). 16. H. Nikjoo, P. O'Neil, E. Wilson, D. Goodhead and M. Terrissol, "Computational modelling of low-energy electron-induced DNA damage by early physical and chemical events," International Journal of Radiation and Biology 71, (1997). 17. H. Nikjoo, P. O'Neil, E. Wilson and D. Goodhead, "Computational Approach for Determining the Spectrum of DNA Damage Induced by Ionizing Radiation," Radiation Research 156, (2001). 18. V. Semenenko and R. Stewart, "Monte Carlo Simulation of Base and Nucleotide Excision Repair of Clustered DNA Damage Sites. II. Comparations of Model Predictions to Measured Data," Radiation Research 164, (2005). 19. R. Sachs, P. Hahnfeld and D. Brenner, "The link between low-let dose-response relations and the underlying kinetics of damage production/repair/misrepair," International Journal of Radiation and Biology 72, (1997). 20. M. Guerrero, R. Stewart, J. Wang and X. Li, "Equivalence of linear-quadratric and twolesion kinetic models," Physics in Medicine and Biology 47, (2002). 21. R. Howell, "Radiation Spectra for Auger-Electron Emitting Radionuclides: Report No.2 of AAPM Nuclear Medicine Task Group No.6," Medical Physics 19, (1992). 22. R. Baserga, "The Cell Cycle and Cancer," in The Biochemistry of Disease - A Molecular Approach to Cell Pathology - Volume I, Vol. I, edited by E. Farber (Marcel Dekker, USA, 1971), pp R. Baserga, "Definig the Cycle," in Cell Biology - Organelle Structure and Function, edited by D. Sadava (Jone and Barlett Publishers, USA, 1993). 14
15 24. UNSCEAR, "Report of the United Nations Scientific Committee on the Effects of Atomic Radiation to the General Assembly," edited by U. N. S. C. o. t. E. o. A. Radiation (2007). 25. E. Pomplun, M. Terrissol and E. Kümmerle, "Estimation of Radiation Weighting Factor for 99m Tc," Radiation Protection Dosimetry 122, (2006). 26. M. Pedraza-López, G. Ferro-Flores, M. Mendiola-Cruz and P. Moralez-Ramírez, "Assessment of Radiation-Induced DNA Damage Caused by the Incorporation of Tc-99m- Radiopharmaceuticals in Murine Lymphocytes Using Cell Gel Electrophoresis," Mutation Research 465, (2000). 27. A. Ílknur, E. Vardereli, B. Durak, Z. Gülbas, N. Basaran, M. Stokkel and E. Pauwels, "Labeling of Mixed Leukocytes with 99m Tc-HMPAO Causes Severe Chromosomal Aberrations in Lymphocytes," Journal of Nuclear Medicine 43, (2002). 28. P. Häfliger, N. Agorastos, B. Spingler, O. Georgiev, G. Viola and R. Alberto, "Induction of DNA-Double-Strand Breaks by Auger Electrons from 99m Tc Complexes with DNA-Binding Ligands," ChemBioChem 6, (2005). 29. S. Ftácniková and R. Böhm, "Monte Carlo Calculations of Energy Deposition in DNA for Auger Emitters," Radiation Protection Dosimetry 92, (2000). 15
16 TABLE CAPTION Table I. Input conditions for MCDS and MCER simulators. 16
17 TABLE I Energy Yield/Decay Particle [MeV] CK MMX Input conditions Auger MXY Auger LMM Auger LMX Auger LXY Auger KLL Auger KLX IC 1 M, N IC 2 K IC 3 K IC 2 L IC 3 L IC 2 M, N Beta I MCDS e MCER: Initial cell number = 1000 DMSO concentration = 0 (normal cell environment) MCER: Inhibition distance = 3 bp Probability of choosing a lesion from the first strand break (P1) = 0.5 Polymerase error rate for SP-BER=1.0-4 Polymerase error rate for LP-BER and NER = Probability of incorrect insertion opposite damaged base = 0.75 Probability of incorrect insertion of opposite base lost = 0.75 Alpha At
18 FIGURE CAPTIONS Fig. 1. a) Percentage of DNA radioinduced SSB and DSB after irradiation with 99m Tc electrons, 131 I beta minus particles and 211 At alpha particles (MCDS simulator). b) Percentage of two SSB on the same DNA segment (2SSB/DNA seg), two or more SSB on opposite DNA segments and separated by at least 10 base pairs (2 or +SSB DNA); and percentage of one DSB and one or more SSB separated by a maximum of 10 base pairs (DSB & 1 or + SSB) and one or more DSB separated by a maximum of 10 base pairs (1 or +DSB 10 bp), after irradiation with 99m Tc electrons, 131 I beta minus particles and 211 At alpha particles (MCDS simulator). c) Fraction of complex SSB and DSB DNA damages after irradiation with 99m Tc electrons, 131 I beta minus particles and 211 At alpha particles (MCDS simulator). Fig. 2. Probability of correct repair (p correct), repair with mutation (p mutation) and conversion to DSB (p conversion DSB) of DNA SSB, by SP-BER, LP-BER, SP-NER and LP-NER repair methods (MCER simulator). Fig. 3. Average number of repair cycles for all used repair methods and irradiating agents (MCER simulator). Fig. 4. a) Results from mutagenesis probability and induction of enhanced genetic instability simulations; b) average number of lethal mutations per cell; c) neoplastic transformation frequency in two different selected cell types after irradiation with distinct irradiating agents. Simulated doses of 1, 1.5 and 2 Gy during irradiation periods of 2, 6 and 24 hours (VC simulator). Fig. 5. Number of cells that survive irradiation with different irradiating agents a) in a quiescent cell population; b) in a heterogeneous cell population and; c) in cells actively dividing. Simulated doses of 1, 1.5 and 2 Gy during irradiation periods of 2, 6 and 24 hours (VC simulator). 18
19 FIGURES Figure 1 19
20 Figure 2 Figure 3 20
21 Figure 4 Figure 5 21
Comparative analysis of eleven different radioisotopes for palliative. treatment of bone metastases by computational methods
Comparative analysis of eleven different radioisotopes for palliative treatment of bone metastases by computational methods Francisco D. C. Guerra Liberal a, Adriana Alexandre S. Tavares b and João Manuel
More informationEnvironmental Radiation Risk Assessment
Environmental Radiation Risk Assessment Jerome Puskin, PhD Center for Science & Risk Assessment Radiation Protection Division Office of Radiation and Indoor Air (ORIA) 2 Outline 1. Ionizing radiation definitions,
More informationPRINIPLES OF RADIATION THERAPY Adarsh Kumar. The basis of radiation therapy revolve around the principle that ionizing radiations kill cells
PRINIPLES OF RADIATION THERAPY Adarsh Kumar The basis of radiation therapy revolve around the principle that ionizing radiations kill cells Radiotherapy terminology: a. Radiosensitivity: refers to susceptibility
More informationCellulär och molekylär respons på låga doser av joniserande strålning
Cellulär och molekylär respons på låga doser av joniserande strålning Bo Stenerlöw Biomedicinsk strålningsvetenskap Rudbecklaboratoriet Uppsala universitet Bo Stenerlöw Biomedical Radiation Sciences Uppsala
More informationTreating Thyroid Cancer using I-131 Maximum Tolerable Dose Method
Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Christopher Martel, M.Sc., CHP Lisa Thornhill,, NRRPT, RT(NM) Boston University Medical Center Thyroid Carcinoma New cases and deaths in
More information[Image removed due to copyright concerns]
Radiation Chemistry Ionizing radiation produces abundant secondary electrons that rapidly slow down (thermalize) to energies below 7.4 ev, the threshold to produce electronic transitions in liquid water.
More informationThe validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning.
The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning. KAROLINA KOKUREWICZ S U P E R V I S O R S : D I N O J A R O S Z Y N S K I, G I U S E P P E S C
More informationMedical Physics and Radioactivity
Medical Physics and Radioactivity Radioactivity Unstable nucleus Electromagnetic wave particle Atoms which emit electromagnetic radiation or a particle by the spontaneous transformation of their nucleus
More informationAre children more sensitive to radiation than adults?
Are children more sensitive to radiation than adults? By Madan M. Rehani Director of Radiation Protection, European Society of Radiology There is a commonly held belief that children may be two to three
More informationEnvironmental Health and Safety Radiation Safety. Module 1. Radiation Safety Fundamentals
Environmental Health and Safety Radiation Safety Module 1 Radiation Safety Fundamentals Atomic Structure Atoms are composed of a variety of subatomic particles. The three of interest to Health Physics
More information1. In the general symbol cleus, which of the three letters. 2. What is the mass number of an alpha particle?
1. In the general symbol cleus, which of the three letters Z A X for a nu represents the atomic number? 2. What is the mass number of an alpha particle? 3. What is the mass number of a beta particle? 4.
More informationBasics of Nuclear Physics and Fission
Basics of Nuclear Physics and Fission A basic background in nuclear physics for those who want to start at the beginning. Some of the terms used in this factsheet can be found in IEER s on-line glossary.
More informationAutoradiograph of Ra-223
Session 4 Radiation protection of patients, staff and the public during therapeutic use of sealed and unsealed radioactive sources Summary of Contributed Papers Makoto Hosono, MD PhD Kinki University School
More informationR. Julian Preston NHEERL U.S. Environmental Protection Agency Research Triangle Park North Carolina. Ninth Beebe Symposium December 1, 2010
Low Dose Risk Estimation: The Changing Face of Radiation Risk Assessment? R. Julian Preston NHEERL U.S. Environmental Protection Agency Research Triangle Park North Carolina Ninth Beebe Symposium December
More informationGuided Notes: Chapter 9 Cellular Reproduction
Guided Notes: Cellular Reproduction When do cells divide? Cells grow and function normally until they become too. Cell size is because increases faster than This means that there is not enough area on
More informationBasic Radiation Therapy Terms
Basic Radiation Therapy Terms accelerated radiation: radiation schedule in which the total dose is given over a shorter period of time. (Compare to hyperfractionated radiation.) adjuvant therapy (add-joo-vunt):
More informationCHAPTER 2: UNDERSTANDING CANCER
CHAPTER 2: UNDERSTANDING CANCER INTRODUCTION We are witnessing an era of great discovery in the field of cancer research. New insights into the causes and development of cancer are emerging. These discoveries
More informationTherapy with protons and ion beams
Therapy with protons and ion beams Biomedical Physics Lecture WiSe 2012/13 many slides from J. Willkens (TUM) Key quesions: How does ion cancer therapy work? What is the physics behind it? How can physics
More informationIndustrial tracers - Finding leaks and blockages
Cancer Treatment Alpha radiation is used to treat various forms of cancer. This process, called unsealed source radiotherapy, involves inserting tiny amounts of radium-226 into cancerous organs. The alpha
More informationFACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
More informationOutline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice
Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment Radiation Biology Outline Introduction: Predictive assays in radiation therapy Examples for specific tumors Immunotherapy Summary
More informationDosimetry for Beta-Emitter Radionuclides by Means of Monte Carlo Simulations
110 Dosimetry for Beta-Emitter Radionuclides by Means of Monte Carlo Simulations Pedro Pérez 1, Francesca Botta 2, Guido Pedroli 2 and Mauro Valente 3 1 Agencia Nacional de Promoción Científica y Tecnológica
More informationThe Need for a PARP in vivo Pharmacodynamic Assay
The Need for a PARP in vivo Pharmacodynamic Assay Jay George, Ph.D., Chief Scientific Officer, Trevigen, Inc., Gaithersburg, MD For further infomation, please contact: William Booth, Ph.D. Tel: +44 (0)1235
More informationMedical Applications of radiation physics. Riccardo Faccini Universita di Roma La Sapienza
Medical Applications of radiation physics Riccardo Faccini Universita di Roma La Sapienza Outlook Introduction to radiation which one? how does it interact with matter? how is it generated? Diagnostics
More informationCell, Tissue and Tumor Kinetics
Cell, issue and umor Kinetics Proliferation Kinetics: rate of growth of a population, change in total cell number. Adult tissues are in homeostasis. Children (and tumors) grow. I. Quantitative Assessment
More informationMUTATION, DNA REPAIR AND CANCER
MUTATION, DNA REPAIR AND CANCER 1 Mutation A heritable change in the genetic material Essential to the continuity of life Source of variation for natural selection New mutations are more likely to be harmful
More informationIntroduction to the Monte Carlo method
Some history Simple applications Radiation transport modelling Flux and Dose calculations Variance reduction Easy Monte Carlo Pioneers of the Monte Carlo Simulation Method: Stanisław Ulam (1909 1984) Stanislaw
More informationACCELERATORS AND MEDICAL PHYSICS 2
ACCELERATORS AND MEDICAL PHYSICS 2 Ugo Amaldi University of Milano Bicocca and TERA Foundation EPFL 2-28.10.10 - U. Amaldi 1 The icone of radiation therapy Radiation beam in matter EPFL 2-28.10.10 - U.
More informationInclusion of Biological Information in Treatment Planning Optimization Dag Rune Olsen
Inclusion of Biological Information in Treatment Planning Optimization Dag Rune Olsen Institute for Cancer Research, Norwegian Radium Hospital, University of Oslo Theragnostics biological conformality
More informationLesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes
Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes Becoming a cancer cell isn t easy One of the fundamental molecular characteristics of cancer is that it does not develop all at once, but
More informationSeminar 7. Medical application of radioisotopes - radiotherapy
Seminar 7 Medical application of radioisotopes - radiotherapy Radioisotopes in medical diagnosis. Gamma camera. Radionuclide imaging (PET, SPECT). Radiotherapy. Sources of radiation. Treatment planning.
More informationTranslating DNA repair pathways into therapeutic targets: beyond the BRCA1/2 and PARP inhibitor saga. Jorge S Reis-Filho, MD PhD FRCPath
Translating DNA repair pathways into therapeutic targets: beyond the BRCA1/2 and PARP inhibitor saga Jorge S Reis-Filho, MD PhD FRCPath Summary How do PARP inhibitors work? Synthetic lethality Potential
More informationM110.726 The Nucleus M110.727 The Cytoskeleton M340.703 Cell Structure and Dynamics
of Biochemistry and Molecular Biology 1. Master the knowledge base of current biochemistry, molecular biology, and cellular physiology Describe current knowledge in metabolic transformations conducted
More informationThe Master course Medical Radiation Sciences and the new profile Medical Radiobiology
OncoRay National Center for Radiation Research in Oncology, Dresden The Master course Medical Radiation Sciences and the new profile Medical Radiobiology Mario Helm Outline Teaching at OncoRay Postgraduate
More informationCancer: Cells Behaving Badly
Cancer: Cells behaving badly It s quite likely your body is harboring precancerous cells. Don t panic: this doesn t mean you have cancer. Many of us have cells here and there with defense mechanisms that
More information90 degrees Bremsstrahlung Source Term Produced in Thick Targets by 50 MeV to 10 GeV Electrons
SLAC-PUB-7722 January 9 degrees Bremsstrahlung Source Term Produced in Thick Targets by 5 MeV to GeV Electrons X. S. Mao et al. Presented at the Ninth International Conference on Radiation Shielding, Tsukuba,
More information1 Mutation and Genetic Change
CHAPTER 14 1 Mutation and Genetic Change SECTION Genes in Action KEY IDEAS As you read this section, keep these questions in mind: What is the origin of genetic differences among organisms? What kinds
More information1. Orthovoltage vs. megavoltage x-rays. (AL) External beam radiation sources: Orthovoltage radiotherapy: 200-500 kv range
1. Orthovoltage vs. megavoltage x-rays. (AL) External beam radiation sources: Orthovoltage radiotherapy: 200-500 kv range The radiation from orthovoltage units is referred to as x-rays, generated by bombarding
More informationEnhanced cytotoxicity of PARP inhibition in Mantle Cell Lymphoma harboring mutations in both ATM and p53
Manuscript EMM-2011-00864 Enhanced cytotoxicity of PARP inhibition in Mantle Cell Lymphoma harboring mutations in both ATM and p53 Chris T. Williamson, Eiji Kubota, Jeffrey D. Hamill, Alexander Klimowicz,
More informationRadiation Detection and Measurement
Radiation Detection and Measurement June 2008 Tom Lewellen Tkldog@u.washington.edu Types of radiation relevant to Nuclear Medicine Particle Symbol Mass (MeV/c 2 ) Charge Electron e-,! - 0.511-1 Positron
More informationIn vivo dose response assays
In vivo dose response assays Tumor assays 1. Tumor growth measurements; tumor growth delay. After irradiation, the tumor is measured daily to determine the mean diameter, or volume. Plot tumor size versus
More informationForensic DNA Testing Terminology
Forensic DNA Testing Terminology ABI 310 Genetic Analyzer a capillary electrophoresis instrument used by forensic DNA laboratories to separate short tandem repeat (STR) loci on the basis of their size.
More informationHADRON THERAPY FOR CANCER TREATMENT
HADRON THERAPY FOR CANCER TREATMENT Seminar presented by Arlene Lennox at Fermilab on Nov 21, 2003 CANCER STAGES LOCAL TUMOR REGIONAL METASTASIS SYSTEMIC DISEASE CANCER TREATMENT SURGERY RADIATION THERAPY
More informationNotch 1 -dependent regulation of cell fate in colorectal cancer
Notch 1 -dependent regulation of cell fate in colorectal cancer Referees: PD Dr. Tobias Dick Prof. Dr. Wilfried Roth http://d-nb.info/1057851272 CONTENTS Summary 1 Zusammenfassung 2 1 INTRODUCTION 3 1.1
More informationAppendix C DNA Replication & Mitosis
K.Muma Bio 6 Appendix C DNA Replication & Mitosis Study Objectives: Appendix C: DNA replication and Mitosis 1. Describe the structure of DNA and where it is found. 2. Explain complimentary base pairing:
More informationSimulation of Proton Therapy Treatment Verification via PET imaging of Induced Positron-Emitters
C-A/AP/#122 November 23 Simulation of Proton Therapy Treatment Verification via PET imaging of Induced Positron-Emitters J. Beebe-Wang, P. Vaska, F.A. Dilmanian, S.G. Peggs and D.J. Schlyer "This paper
More informationNuclear Physics. Nuclear Physics comprises the study of:
Nuclear Physics Nuclear Physics comprises the study of: The general properties of nuclei The particles contained in the nucleus The interaction between these particles Radioactivity and nuclear reactions
More informationRadiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012
Radiation Oncology Nursing Care Helen Lusby Radiation Oncology Nurse BAROC 2012 Definitions Radiation Therapy: Treatment of cancer using x- ray particles that cause ionisation within the cells. External
More informationM. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2
M. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2 1 Department of Physics, University of Pavia, Pavia, Italy 2 Istituto Nazionale
More informationManual for simulation of EB processing. Software ModeRTL
1 Manual for simulation of EB processing Software ModeRTL How to get results. Software ModeRTL. Software ModeRTL consists of five thematic modules and service blocks. (See Fig.1). Analytic module is intended
More informationC A M P E P. Standards for Accreditation of Graduate Educational Programs in Medical Physics
Standards for Accreditation of Graduate Educational Programs in Medical Physics Preamble Revised July 2015 Medical Physics is a branch of physics that applies the concepts and principles of physics to
More informationRobert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
More informationCancer: Genetic testing can save lives
Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who
More informationHow Cancer Begins???????? Chithra Manikandan Nov 2009
Cancer Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common cancer in men Breast cancer
More informationRadium-223 Therapy: Handling & Radiation Safety Issues
Nuclear Physics Enterprises Radium-223 Therapy: Handling & Radiation Safety Issues Jeffry A. Siegel, Ph.D. President & CEO 2014 Meeting Mid-Atlantic States Radiation Control Programs Malvern, PA NRC s
More informationRadiopharmaceuticals that can be used for alleviating pain caused by bone metastases:
Methodological letter of Nuclear Medicine Professional College and Radiotherapy and Oncology Professional College on the treatment of bone metastases with open radioactive isotopes Bone metastases of tumours
More information4. DNA replication Pages: 979-984 Difficulty: 2 Ans: C Which one of the following statements about enzymes that interact with DNA is true?
Chapter 25 DNA Metabolism Multiple Choice Questions 1. DNA replication Page: 977 Difficulty: 2 Ans: C The Meselson-Stahl experiment established that: A) DNA polymerase has a crucial role in DNA synthesis.
More informationChapter 6 DNA Replication
Chapter 6 DNA Replication Each strand of the DNA double helix contains a sequence of nucleotides that is exactly complementary to the nucleotide sequence of its partner strand. Each strand can therefore
More informationChapter NP-5. Nuclear Physics. Nuclear Reactions TABLE OF CONTENTS INTRODUCTION OBJECTIVES 1.0 NUCLEAR REACTIONS 2.0 NEUTRON INTERACTIONS
Chapter NP-5 Nuclear Physics Nuclear Reactions TABLE OF CONTENTS INTRODUCTION OBJECTIVES 1.0 2.0 NEUTRON INTERACTIONS 2.1 ELASTIC SCATTERING 2.2 INELASTIC SCATTERING 2.3 RADIATIVE CAPTURE 2.4 PARTICLE
More informationFuture Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
More informationAtomic and Nuclear Physics Laboratory (Physics 4780)
Gamma Ray Spectroscopy Week of September 27, 2010 Atomic and Nuclear Physics Laboratory (Physics 4780) The University of Toledo Instructor: Randy Ellingson Gamma Ray Production: Co 60 60 60 27Co28Ni *
More informationBob Jesberg. Boston, MA April 3, 2014
DNA, Replication and Transcription Bob Jesberg NSTA Conference Boston, MA April 3, 2014 1 Workshop Agenda Looking at DNA and Forensics The DNA, Replication i and Transcription i Set DNA Ladder The Double
More informationMain properties of atoms and nucleus
Main properties of atoms and nucleus. Atom Structure.... Structure of Nuclei... 3. Definition of Isotopes... 4. Energy Characteristics of Nuclei... 5. Laws of Radioactive Nuclei Transformation... 3. Atom
More informationCCR Biology - Chapter 9 Practice Test - Summer 2012
Name: Class: Date: CCR Biology - Chapter 9 Practice Test - Summer 2012 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Genetic engineering is possible
More informationComparative genomic hybridization Because arrays are more than just a tool for expression analysis
Microarray Data Analysis Workshop MedVetNet Workshop, DTU 2008 Comparative genomic hybridization Because arrays are more than just a tool for expression analysis Carsten Friis ( with several slides from
More informationActivitity (of a radioisotope): The number of nuclei in a sample undergoing radioactive decay in each second. It is commonly expressed in curies
Activitity (of a radioisotope): The number of nuclei in a sample undergoing radioactive decay in each second. It is commonly expressed in curies (Ci), where 1 Ci = 3.7x10 10 disintegrations per second.
More informationGene Mapping Techniques
Gene Mapping Techniques OBJECTIVES By the end of this session the student should be able to: Define genetic linkage and recombinant frequency State how genetic distance may be estimated State how restriction
More informationRADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC
More informationChemistry 102 Summary June 24 th. Properties of Light
Chemistry 102 Summary June 24 th Properties of Light - Energy travels through space in the form of electromagnetic radiation (EMR). - Examples of types of EMR: radio waves, x-rays, microwaves, visible
More informationDNA Fingerprinting. Unless they are identical twins, individuals have unique DNA
DNA Fingerprinting Unless they are identical twins, individuals have unique DNA DNA fingerprinting The name used for the unambiguous identifying technique that takes advantage of differences in DNA sequence
More informationMechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies. Biochemistry Journal. August 1, 2007 405, pp.
Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies 1 Biochemistry Journal August 1, 2007 405, pp. 559 568 Joseph Friedman, Sarah Kraus, Yirmi Hauptman, Yoni Schiff
More informationAsexual Versus Sexual Reproduction in Genetic Algorithms 1
Asexual Versus Sexual Reproduction in Genetic Algorithms Wendy Ann Deslauriers (wendyd@alumni.princeton.edu) Institute of Cognitive Science,Room 22, Dunton Tower Carleton University, 25 Colonel By Drive
More informationJust the Facts: A Basic Introduction to the Science Underlying NCBI Resources
1 of 8 11/7/2004 11:00 AM National Center for Biotechnology Information About NCBI NCBI at a Glance A Science Primer Human Genome Resources Model Organisms Guide Outreach and Education Databases and Tools
More information2. True or False? The sequence of nucleotides in the human genome is 90.9% identical from one person to the next. False (it s 99.
1. True or False? A typical chromosome can contain several hundred to several thousand genes, arranged in linear order along the DNA molecule present in the chromosome. True 2. True or False? The sequence
More informationHow To Use A Proton For Radiation Therapy
Proton Cancer Therapy: Using Laser Accelerate Protons for Radiation Therapy A Thesis Submitted in Partial Fulfillment of the Requirements for Graduation with Research Distinction in Engineering Physics
More informationNovel Radionuclide Therapies in Oncology : Promising Area in the Field of Nuclear Medicine
Novel Radionuclide Therapies in Oncology : Promising Area in the Field of Nuclear Medicine Erik Mittra, MD, PhD Clinical Assistant Professor Radiology / Nuclear Medicine Objectives / Outline 1. Understand
More informationBasic Nuclear Concepts
Section 7: In this section, we present a basic description of atomic nuclei, the stored energy contained within them, their occurrence and stability Basic Nuclear Concepts EARLY DISCOVERIES [see also Section
More informationTutorial 4.6 Gamma Spectrum Analysis
Tutorial 4.6 Gamma Spectrum Analysis Slide 1. Gamma Spectrum Analysis In this module, we will apply the concepts that were discussed in Tutorial 4.1, Interactions of Radiation with Matter. Slide 2. Learning
More informationChapter 8: Recombinant DNA 2002 by W. H. Freeman and Company Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company
Genetic engineering: humans Gene replacement therapy or gene therapy Many technical and ethical issues implications for gene pool for germ-line gene therapy what traits constitute disease rather than just
More information2 Absorbing Solar Energy
2 Absorbing Solar Energy 2.1 Air Mass and the Solar Spectrum Now that we have introduced the solar cell, it is time to introduce the source of the energy the sun. The sun has many properties that could
More informationThe Phenomenon of Photoelectric Emission:
The Photoelectric Effect. The Wave particle duality of light Light, like any other E.M.R (electromagnetic radiation) has got a dual nature. That is there are experiments that prove that it is made up of
More informationComments on the Draft Report by the California Council on Science and Technology Health Impacts of Radio Frequency from Smart Meters
Comments on the Draft Report by the California Council on Science and Technology Health Impacts of Radio Frequency from Smart Meters by Daniel Hirsch 1 31 January 2011 Abstract The draft report by the
More informationProduction of X-rays. Radiation Safety Training for Analytical X-Ray Devices Module 9
Module 9 This module presents information on what X-rays are and how they are produced. Introduction Module 9, Page 2 X-rays are a type of electromagnetic radiation. Other types of electromagnetic radiation
More informationCell Phone Radiation and Genomic Damage: In Vitro Exposure and Assessment
Cell Phone Radiation and Genomic Damage: In Vitro Exposure and Assessment Chinar Shah 1, Anu Nair 1, Mehul Naik 2, Sonal Bakshi 3 Institute of Science, Nirma University, Ahmedabad, Gujarat, India 1 Electronics
More informationCell Division Mitosis and the Cell Cycle
Cell Division Mitosis and the Cell Cycle A Chromosome and Sister Chromatids Key Points About Chromosome Structure A chromosome consists of DNA that is wrapped around proteins (histones) and condensed Each
More informationHow many of you have checked out the web site on protein-dna interactions?
How many of you have checked out the web site on protein-dna interactions? Example of an approximately 40,000 probe spotted oligo microarray with enlarged inset to show detail. Find and be ready to discuss
More informationLESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5
LESSON 3.5 WORKBOOK How do cancer cells evolve? In this unit we have learned how normal cells can be transformed so that they stop behaving as part of a tissue community and become unresponsive to regulation.
More informationINSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific
More informationWhat is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:
Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic
More informationOnline checking of radiation dose for Computed Tomography imaging investigations performed on the human patients. Alin CORDOS 1
Advanced Engineering Forum Online: 2013-06-27 ISSN: 2234-991X, Vols. 8-9, pp 21-28 doi:10.4028/www.scientific.net/aef.8-9.21 2013 Trans Tech Publications, Switzerland Online checking of radiation dose
More informationDNA Replication and Repair
DNA Replication and Repair This lecture explores the mechanisms of DNA replication and also the ways in which DNA can repair any replication errors. It also looks at some of the causes of DNA damage and
More informationThe Biotechnology Education Company
EDVTEK P.. Box 1232 West Bethesda, MD 20827-1232 The Biotechnology 106 EDV-Kit # Principles of DNA Sequencing Experiment bjective: The objective of this experiment is to develop an understanding of DNA
More informationAn Innovative Method for Dead Time Correction in Nuclear Spectroscopy
An Innovative Method for Dead Time Correction in Nuclear Spectroscopy Upp, Daniel L.; Keyser, Ronald M.; Gedcke, Dale A.; Twomey, Timothy R.; and Bingham, Russell D. PerkinElmer Instruments, Inc. ORTEC,
More informationHereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013
Hereditary Ovarian cancer: BRCA1 and BRCA2 Karen H. Lu MD September 22, 2013 Outline Hereditary Breast and Ovarian Cancer (HBOC) BRCA1/2 genes How to identify What it means to you What it means to your
More informationName Date Period. 2. When a molecule of double-stranded DNA undergoes replication, it results in
DNA, RNA, Protein Synthesis Keystone 1. During the process shown above, the two strands of one DNA molecule are unwound. Then, DNA polymerases add complementary nucleotides to each strand which results
More informationAntoine Henri Becquerel was born in Paris on December 15, 1852
Discovery Antoine Henri Becquerel was born in Paris on December 15, 1852 Summit Environmental Technologies, Inc. Analytical Laboratories 3310 Win Street Cuyahoga Falls, Ohio 44223 Fax: 1-330-253-4489 Call
More informationGENE REGULATION. Teacher Packet
AP * BIOLOGY GENE REGULATION Teacher Packet AP* is a trademark of the College Entrance Examination Board. The College Entrance Examination Board was not involved in the production of this material. Pictures
More informationFrom DNA to Protein. Proteins. Chapter 13. Prokaryotes and Eukaryotes. The Path From Genes to Proteins. All proteins consist of polypeptide chains
Proteins From DNA to Protein Chapter 13 All proteins consist of polypeptide chains A linear sequence of amino acids Each chain corresponds to the nucleotide base sequence of a gene The Path From Genes
More informationCancer Therapy with Particle Beams
Cancer Therapy with Particle Beams The potential to use high energy particle beams to treat many types of cancer has been known even before their creation. The availability of these treatments has been
More informationRadiation and Pregnancy
Radiation and Pregnancy General Special attention must be paid to the pregnant, potentially pregnant, or breast feeding patient. The developing embryo or fetus is particularly sensitive to radiation. If
More information